IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 19 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $139,000 | +631.6% | 24,409 | +259.9% | 0.00% | – |
| Q3 2018 | $19,000 | +46.2% | 6,783 | +17.7% | 0.00% | – |
| Q2 2018 | $13,000 | +333.3% | 5,761 | +262.3% | 0.00% | – |
| Q1 2018 | $3,000 | -78.6% | 1,590 | -81.1% | 0.00% | – |
| Q4 2017 | $14,000 | -50.0% | 8,398 | -52.0% | 0.00% | – |
| Q3 2017 | $28,000 | -60.0% | 17,500 | -19.9% | 0.00% | – |
| Q2 2017 | $70,000 | +536.4% | 21,853 | +729.0% | 0.00% | – |
| Q1 2017 | $11,000 | +83.3% | 2,636 | +16.3% | 0.00% | – |
| Q4 2016 | $6,000 | +100.0% | 2,266 | +158.1% | 0.00% | – |
| Q3 2016 | $3,000 | -70.0% | 878 | -64.3% | 0.00% | – |
| Q1 2016 | $10,000 | +900.0% | 2,461 | +1088.9% | 0.00% | – |
| Q4 2015 | $1,000 | -50.0% | 207 | -14.5% | 0.00% | – |
| Q1 2015 | $2,000 | -90.9% | 242 | -91.6% | 0.00% | – |
| Q4 2014 | $22,000 | – | 2,869 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|